 An open-label, randomized, 3-period crossover study to evaluate sumatriptan pharmacokinetics for a TREXIMATM sumatriptan succinate naproxen sodium Tablet followed by IMITREX sumatriptan succinate Injection 4mg administered using the IMITREX STATdose System and a TREXIMA tablet followed by IMITREX sumatriptan succinate Injection 6mg administered using the IMITREX STATdose System compared with an IMITREX Tablet 100mg followed by an IMITREX Tablet 100mg. 